Optimization of growth hormone dosing in children born small for gestational age: An open-label, randomized study of children during the fourth year of therapy

Hormone Research in Paediatrics

Volumn 77, Issue 3, 2012, Pages 156-162

  Chatelain, P ^a   Colle, M ^d   Nako, J P ^b   Le Luyer, B ^e   Wagner, K ^f   Berlier, P ^c   Tauber, M ^g  

^a UNIVERSITÉ LYON 1   (France)

^b Merck KGaA France   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d Centre d'Endocrinologie Pediatrique   (France)

^e LE HAVRE HOSPITAL   (France)

^f CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^g HÔPITAL DES ENFANTS   (France)

Author keywords

Catch up growth; Growth hormone; Pediatric growth hormone therapy; Small for gestational age

Indexed keywords

RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ABNORMAL LABORATORY RESULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASTHMA; BODY HEIGHT; BODY WEIGHT; BRONCHITIS; CATCH UP GROWTH; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; EAR INFECTION; EMERGENCY CARE; FEMALE; HORMONAL THERAPY; HUMAN; INSULINEMIA; LOW DRUG DOSE; MALE; OPEN STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; SMALL FOR DATE INFANT; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; WEIGHT GAIN;

BODY HEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN-LIKE GROWTH FACTOR I; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84859641685     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000337216     Document Type: Article

References (25)

1. Albanese A, Stanhope R: Growth and metabolic data following growth hormone treatment of children with intrauterine growth retardation. Horm Res 1993; 39: 8-12. (Pubitemid 23243131)
2. Chatelain P, Job JC, Blanchard J, Ducret JP, Oliver M, Sagnard L, Vanderschueren- Lodeweyckx M: Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. Belgian and French Pediatric Clinics and Sanofi-Choay (France). J Clin Endocrinol Metab 1994; 78: 1454-1460. (Pubitemid 24181020)
3. De Zegher F, Albertsson-Wikland K, Wilton P, Chatelain P, Jonsson B, Lofstrom A, Butenandt O, Chaussain JL: Growth hormone treatment of short children born small for gestational age: meta-analysis of four independent, randomized, controlled, multicentre studies. Acta Paediatr Suppl 1996; 417: 27-31. (Pubitemid 27115739)
4. De Zegher F, Hokken-Koelega A: Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term. Pediatrics 2005; 115:e458-e462.
5. Fjellestad-Paulsen A, Czernichow P, Brauner R, Bost M, Colle M, Lebouc JY, Lecornu M, Leheup B, Limal JM, Raux MC, Toublanc JE, Rappaport R: Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation. Acta Paediatr 1998; 87: 511-517. (Pubitemid 28257289)
6. Job JC, Chaussain JL, Job B, Ducret JP, Maes M, Olivier M, Ponte C, Rochiccioli P, Vanderschueren- Lodeweyckx M, Chatelain P: Follow- up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onset. Pediatr Res 1996; 39: 354-359.
7. Maiorana A, Cianfarani S: Impact of growth hormone therapy on adult height of children born small for gestational age. Pediatrics 2009; 124:e519-e531.
8. Phillip M, Lebenthal Y, Lebl J, Zuckerman- Levin N, Korpal-Szczyrska M, Marques JS, Steensberg A, Jons K, Kappelgaard AM, Ibanez L: European multicentre study in children born small for gestational age with persistent short stature: comparison of continuous and discontinuous growth hormone treatment regimens. Horm Res 2009; 71: 52-59.
9. Tanner JM, Lejarraga H, Cameron N: The natural history of the Silver-Russell syndrome: a longitudinal study of thirty-nine cases. Pediatr Res 1975; 9: 611-623.
10. De Waal WJ, Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL: Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone. Clin Endocrinol (Oxf) 1994; 41: 621-630. (Pubitemid 24336865)
11. Boonstra VH, Arends NJ, Stijnen T, Blum WF, Akkerman O, Hokken-Koelega AC: Food intake of children with short stature born small for gestational age before and during a randomized GH trial. Horm Res 2006; 65: 23-30. (Pubitemid 43177314)
12. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A: Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab 2007; 92: 804-810. (Pubitemid 46465644)
13. Fjellestad-Paulsen A, Simon D, Czernichow P: Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment. J Clin Endocrinol Metab 2004; 89: 1234-1239. (Pubitemid 38368419)
14. Edouard T, Oliver I, Jouret B, Lounis N, Moulin P, Pienkowski C, Elefterion M, Salles JP, Tauber M: Growth follow-up of SGA children after 3 years of GH treatment (in French). Arch Pediatr 2008; 15: 115-121.
15. Hokken-Koelega AC, De Ridder MA, Lemmen RJ, Den Hartog H, de Muinck Keizer- Schrama SM, Drop SL: Children born small for gestational age: do they catch up? Pediatr Res 1995; 38: 267-271.
16. Greulich WW, Pyle S: Radiographic Atlas of Skeletal Development of Hand and Wrist, ed 2. Palo Alto, Stanford University Press, 1959.
17. Sassolas G, Chatelain P, Cohen R, Boissel JP, Laporte S, Galleyrand J, Claustrat B, Elmcharfi A, Chayvialle JA, Cohen H, Ferry S, Underwood L: Effects of human pancreatic tumor growth hormone-releasing hormone (hpGRH1-44-NH2) on immunoreactive and bioactive plasma growth hormone in normal young men. J Clin Endocrinol Metab 1984; 59: 705-709. (Pubitemid 14012494)
18. Committee for Proprietary Medicinal Products (CPMP): Points to consider on adjustment for baseline covariates. Stat Med 2004; 23: 701-709.
19. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG: Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 2007; 92: 2480-2486. (Pubitemid 47037346)
20. Chatelain P, Carrascosa A, Bona G, Ferrandez- Longas A, Sippell W: Growth hormone therapy for short children born small for gestational age. Horm Res 2007; 68: 300-309. (Pubitemid 350059705)
21. Labarta JI, Ruiz JA, Molina I, de Arriba A, Mayayo E, Longas AF: Growth and growth hormone treatment in short stature children born small for gestational age. Pediatr Endocrinol Rev 2009; 6(suppl 3):350-357.
22. Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P: International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 2003; 111: 1253-1261. (Pubitemid 36682257)
23. Gharib H, Cook DM, Saenger PH, Bengtsson BA, Feld S, Nippoldt TB, Rodbard HW, Seibel JA, Vance ML, Zimmerman D: American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children - 2003 update. Endocr Pract 2003; 9: 64-76.
24. De Zegher F, Albertsson-Wikland K, Wollmann HA, Chatelain P, Chaussain JL, Lofstrom A, Jonsson B, Rosenfeld RG: Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years. J Clin Endocrinol Metab 2000; 85: 2816-2821. (Pubitemid 32269158)
25. Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A: Adult height after long-term, continuous growth hormone treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response growth hormone trial. J Clin Endocrinol Metab 2003; 88: 3584-3590. (Pubitemid 37034499)